Business Insider
My Markets Watchlist
Markets Stocks

Ardelyx Inc Stock , ARDX

3.59 -0.14 -3.63%
03:59:59 PM EDT 6/13/2025 BTT
News Analyst Data Analyst Opinions Insider Activity Dividend Calendar

On Friday 06/13/2025 the closing price of the Ardelyx Inc share was $3.72 on BTT. Compared to the opening price on Friday 06/13/2025 on BTT of $3.67, this is a gain of 1.48%. Ardelyx Inc's market capitalization is $698.86 M by 239.26 M shares outstanding.
Is Ardelyx stock a Buy, Sell or Hold? Ardelyx stock has received a consensus rating of buy. The average rating score is and is based on 19 buy ratings, 7 hold ratings, and 0 sell ratings.
What was the 52-week low for Ardelyx stock? The low in the last 52 weeks of Ardelyx stock was 3.22. According to the current price, Ardelyx is 111.34% away from the 52-week low.
What was the 52-week high for Ardelyx stock? The high in the last 52 weeks of Ardelyx stock was 8.05. According to the current price, Ardelyx is 44.53% away from the 52-week high.
What are analysts forecasts for Ardelyx stock? The 26 analysts offering price forecasts for Ardelyx have a median target of 11.42, with a high estimate of 15.00 and a low estimate of 5.50. The median estimate represents a 31.38 difference from the last price of 3.59.

Ardelyx Stock Snapshot

3.58
Bid
5.00
Bid Size
3.77
Ask
136.00
Ask Size
6/13/2025
Date
3:59 PM
Time
276,680.00
Volume
3.72
Prev. Close
3.67
Open
861.32 M
Market Cap in USD
239.26 M
Number of Shares
239.26 M
Total Number of Shares
3.59
Day Low
3.78
Day High
3.59
3.22
52 Week Low
8.05
52 Week High
3.59
0.00
Dividend in USD
0.00
Dividend Yield
96.51
Free Float in %
-0.17
EPS in USD
0.73
Book Value per Share in USD
-0.19
Cash Flow per Share in USD

Historical Prices for Ardelyx

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

Ardelyx Analyst Data

Total Analysts: 26
Buy Ratings: 19 Neutral Ratings: 7 Sell Ratings: 0
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price *Price Target
Lowest: 5.50 Median: 11.42 Highest: 15.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

Ardelyx Analyst Opinions

  • All
  • Buy
  • Hold
  • Sell
Date Analyst Rating Price
05/02/25 Citigroup Corp.
Maintained Buy $10
03/07/25 Ladenburg Thalmann & Co. Inc.
Maintained Buy $11
02/21/25 Raymond James Financial, Inc.
Maintained Buy $13
02/21/25 H.C. Wainwright & Co.
Maintained Hold $5.5
01/27/25 Piper Sandler
Maintained Hold $8
07/18/24 H.C. Wainwright & Co.
Maintained Buy $10
07/18/24 Wedbush Morgan Securities Inc.
Maintained Buy $11
07/03/24 Citigroup Corp.
Maintained Buy $10
06/20/24 Cantor Fitzgerald
Maintained Buy
05/24/24 Piper Sandler
Maintained Buy $15
05/24/24 Wedbush Morgan Securities Inc.
Maintained Buy $15
05/03/24 Citigroup Corp.
Maintained Buy $14
05/03/24 Wedbush Morgan Securities Inc.
Maintained Buy $15
04/17/24 Wedbush Morgan Securities Inc.
Maintained Buy $14
02/23/24 Piper Sandler
Maintained Buy $15
02/23/24 Wedbush Morgan Securities Inc.
Maintained Buy $13
01/12/24 Wedbush Morgan Securities Inc.
Maintained Buy $13
01/10/24 Citigroup Corp.
Maintained Buy $14
01/09/24 Raymond James Financial, Inc.
Maintained Buy $15
12/18/23 Raymond James Financial, Inc.
Maintained Buy $12
12/01/23 Wedbush Morgan Securities Inc.
Maintained Buy $9
11/01/23 H.C. Wainwright & Co.
Maintained Buy $11
09/13/23 Wedbush Morgan Securities Inc.
Maintained Buy $7
09/12/23 H.C. Wainwright & Co.
Maintained Buy $9
09/07/23 H.C. Wainwright & Co.
Maintained Buy $9
08/25/23 Cantor Fitzgerald
Upgraded to Buy $10
08/03/23 Ladenburg Thalmann & Co. Inc.
Maintained Buy $8.5

Ardelyx Estimates* in USD

  2025 2026 2027 2028 2029
Revenue 366 493 641 813 916
Dividend 0.00 0.00 - 0.00 -
Dividend Yield (in %) 0.00 % 0.00 % 0.00 % 0.00 % -
EPS -0.38 0.13 0.68 1.13 1.43
P/E Ratio -9.46 27.93 5.31 3.20 2.51
EBIT -74 54 212 361 441
EBITDA -29 93 172 238 302
Net Profit -93 34 178 299 366
Net Profit Adjusted -103 22 113 184 237
Pre-Tax Profit -92 44 199 360 443
Pre-Tax Profit Reported -68 33 105 187 254
EPS (Non-GAAP) ex. SOE -0.43 -0.09 0.38 0.75 0.95
EPS (GAAP) -0.37 0.12 0.65 0.97 1.16
Gross Income 322 473 632 804 936
Cash Flow from Investing 24 12 5 -2 -2
Cash Flow from Operations -31 63 213 405 499
Cash Flow from Financing 0 0 -50 -75 -151
Cash Flow per Share - - - - -
Free Cash Flow - - - - -
Free Cash Flow per Share - - - - -
Book Value per Share - - - - -
Net Debt - - - - -
Research & Development Exp. 61 60 59 62 65
Capital Expenditure 2 2 2 2 2
Selling, General & Admin. Exp. 340 349 332 339 369
Shareholder’s Equity 108 184 428 849 1,279
Total Assets 367 445 637 1,010 1,391
  Previous Quarter
ending 03/31/25 		Current Quarter
ending 06/30/25 		Next Quarter
ending 09/30/25 		Current Year
ending 12/31/25 		Next Year
ending 12/31/26
Earnings Estimates
No. of Analysts - 11 11 11 11
Average Estimate - -0.122 USD -0.068 USD -0.381 USD 0.129 USD
Year Ago - -0.070 USD -0.003 USD -0.166 USD -
Publish Date - 7/31/2025 10/30/2025 - -
Revenue Estimates
No. of Analysts - 11 11 11 11
Average Estimate - 83 USD 97 USD 366 USD 493 USD
Year Ago - 73 USD 98 USD 334 USD -
Publish Date - 7/31/2025 10/30/2025 - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. USD

2024 2023 2022 2021 2020 2019 2018
Sales 333.62 124.46 52.16 10.10 7.57 5.28 2.61
Change of sales in % 168.06 138.61 416.57 33.36 43.36 102.57 -93.79
Gross profit on sales 281.00 105.37 43.44 4.57 3.46 0.34 -0.54
Gross profit on sales change in % 166.68 142.56 850.34 32.30 913.20 - -
Operating income -27.95 -63.28 -63.76 -154.35 -90.78 -91.26 -90.95
Operating income change in % 55.83 0.76 58.69 -70.02 0.53 -0.35 -39.67
Income before tax -38.87 -65.52 -67.20 -158.16 -94.31 -94.64 -91.29
Income before tax change in % 40.67 2.50 57.51 -67.70 0.34 -3.66 -44.54
Income after tax -39.14 -66.07 -67.21 -158.17 -94.31 -94.94 -91.30
Income after tax change in % 40.76 1.70 57.51 -67.70 0.66 -3.99 -41.90

Balance Sheet in Mio. USD

2024 2023 2022 2021 2020 2019 2018
Total liabilities 262.47 130.76 91.74 67.30 75.45 73.13 67.52
Long-term liabilities per share 0.78 0.35 0.13 0.11 0.50 0.57 0.80
Equity 173.29 166.82 98.33 82.62 126.11 186.66 115.81
Equity change in % 3.88 69.65 19.02 -34.49 -32.44 61.17 -16.87
Balance sheet total 435.75 297.58 190.07 149.91 201.56 259.78 183.33
Balance sheet total change in % 46.43 56.57 26.78 -25.62 -22.41 41.70 16.10

Key Data in USD

2024 2023 2022 2021 2020 2019 2018
Sales per share 1.42 0.57 0.33 0.10 0.08 0.08 0.05
P/E ratio (year end quote, basic EPS) - - - - - - -
P/E ratio (year end quote, diluted EPS) - - - - - - -
Dividend yield in % 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity ratio in % 39.77 56.06 51.73 55.11 62.57 71.85 63.17
Debt ratio in % 60.23 43.94 48.27 44.89 37.43 28.15 36.83

Ardelyx Insider Activity

Name Date shares traded shares held Price type (sell/buy) option
MOTT DAVID M 06/08/2025 200,000.00 2,696,871.00 3.69 Buy No
RAAB MICHAEL 05/19/2025 46,817.00 1,547,937.00 4.08 Sell No
Kelliher Mike 05/19/2025 14,522.00 282,158.00 4.08 Sell No
Renz Justin A 05/19/2025 7,218.00 416,089.00 4.08 Sell No
Foster Eric Duane 05/19/2025 2,507.00 316,806.00 4.08 Sell No
Williams Laura A 05/19/2025 6,421.00 402,583.00 4.08 Sell No
RAAB MICHAEL 05/01/2025 41,666.00 1,594,754.00 4.25 Sell No
RAAB MICHAEL 05/01/2025 20,833.00 1,636,420.00 0.99 Buy No
Parsey Merdad 04/27/2025 42,056.00 42,056.00 n/a Buy No
RAAB MICHAEL 04/03/2025 41,666.00 1,615,587.00 4.59 Sell No
RAAB MICHAEL 04/03/2025 20,833.00 1,657,253.00 0.99 Buy No
RAAB MICHAEL 03/06/2025 41,668.00 1,635,138.00 5.36 Sell No
RAAB MICHAEL 03/06/2025 20,834.00 1,676,806.00 0.99 Buy No
Foster Eric Duane 02/24/2025 136,680.00 316,680.00 n/a Buy No
RAAB MICHAEL 01/30/2025 41,666.00 1,108,719.00 5.36 Sell No
RAAB MICHAEL 01/30/2025 20,833.00 1,150,385.00 0.99 Buy No
MOTT DAVID M 01/20/2025 199,000.00 1,937,765.00 4.99 Buy No
Rodgers Richard J 01/15/2025 100,000.00 350,524.00 0.55 Buy No
RAAB MICHAEL 01/06/2025 41,666.00 1,129,552.00 5.31 Sell No
RAAB MICHAEL 01/06/2025 20,833.00 1,171,218.00 0.99 Buy No
MOTT DAVID M 12/25/2024 100,000.00 1,738,765.00 0.55 Buy No
MOTT DAVID M 12/18/2024 213,300.00 1,638,765.00 4.67 Buy No
RAAB MICHAEL 12/09/2024 25,000.00 1,150,385.00 5.26 Sell No
RAAB MICHAEL 12/09/2024 25,000.00 1,175,385.00 0.99 Buy No
RAAB MICHAEL 11/24/2024 25,000.00 1,150,385.00 5.38 Sell No

Ardelyx Dividend Calendar

Date Name Dividend *yield Currency
2024 Ardelyx Inc 0.00 0.00 USD
2023 Ardelyx Inc 0.00 0.00 USD
2022 Ardelyx Inc 0.00 0.00 USD
2021 Ardelyx Inc 0.00 0.00 USD
2020 Ardelyx Inc 0.00 0.00 USD
2019 Ardelyx Inc 0.00 0.00 USD
2018 Ardelyx Inc 0.00 0.00 USD
2017 Ardelyx Inc 0.00 0.00 USD
2016 Ardelyx Inc 0.00 0.00 USD
2015 Ardelyx Inc 0.00 0.00 USD
2014 Ardelyx Inc 0.00 0.00 USD
2013 Ardelyx Inc - - USD
2012 Ardelyx Inc - - USD
*Yield of the Respective Date

Ardelyx Calendar

Event Estimate Info Date
Annual General Meeting -0.170 USD Annual General Meeting 06/18/2025
Earnings Report -0.122 USD Q2 2025 Earnings Release 07/31/2025
Earnings Report -0.068 USD Q3 2025 Earnings Release 10/30/2025
Earnings Report -0.017 USD Q4 2025 Earnings Release 03/11/2026
Earnings Report -0.063 USD Q1 2026 Earnings Release 04/30/2026

Ardelyx Past Events

Event Actual EPS Info Date
Earnings Report -0.170 USD Q1 2025 Earnings Release 05/01/2025
Earnings Report 0.020 USD Q4 2024 Earnings Release 02/20/2025
Earnings Report 0.000 USD Q3 2024 Earnings Release 10/31/2024
Earnings Report -0.070 USD Q2 2024 Earnings Release 08/01/2024
Annual General Meeting -0.300 USD Annual General Meeting 06/14/2024
Earnings Report -0.110 USD Q1 2024 Earnings Release 05/02/2024
Earnings Report -0.120 USD Q4 2023 Earnings Release 02/22/2024
Earnings Report 0.030 USD Q3 2023 Earnings Release 10/31/2023
Earnings Report -0.080 USD Q2 2023 Earnings Release 08/02/2023
Annual General Meeting -0.420 USD Annual General Meeting 06/15/2023
Earnings Report -0.130 USD Q1 2023 Earnings Release 05/03/2023
Earnings Report 0.060 USD Q4 2022 Earnings Release 03/02/2023
Earnings Report -0.140 USD Q3 2022 Earnings Release 11/03/2022
Earnings Report -0.190 USD Q2 2022 Earnings Release 08/04/2022
Annual General Meeting -1.520 USD Annual General Meeting 07/13/2022
Earnings Report -0.210 USD Q1 2022 Earnings Release 05/05/2022
Earnings Report -0.310 USD Q4 2021 Earnings Release 02/28/2022

Ardelyx Profile

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Moody’s Daily Credit Risk Score

Risk
  • Low
  • Medium
  • High
9
Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.
OSZAR »